Does the liver substantially regulate thyroid hormone metabolism?

Thyroid hormone physiology is partly hepatobiliary physiology: the liver modifies circulating hormone activity, prepares metabolites for elimination, and participates in their biliary–intestinal cycling. This relationship becomes clinically relevant in significant liver disease, particularly cirrhosis.

Clinical and metabolic evidence

• Hepatic type 1 deiodinase (DIO1), highly expressed in adult hepatocytes, performs outer-ring deiodination of T4 to active T3 and inner-ring deiodination, including efficient reverse-T3 clearance. Hepatocytes also conjugate iodothyronines through glucuronidation and sulfation; T4 glucuronidation is mediated principally by UGT1A1 and UGT1A3, with contributions from UGT1A9 and UGT1A10.
• In clinically significant liver disease, low total/free T3 and a reduced T3:T4 ratio are common, often with variable T4 and non-suppressed TSH. These changes support impaired T4-to-T3 activation, especially in cirrhosis, but commonly reflect non-thyroidal illness physiology rather than primary thyroid failure.

Mechanisms of clearance and biliary handling

• Glucuronidated hormone metabolites can undergo canalicular biliary export via transporters including MRP2 and BCRP; basolateral export can instead support renal elimination. Intestinal microbial deconjugation may enable reabsorption, creating enterohepatic recycling, whereas non-recycled metabolites are excreted in feces.
• Sulfation can facilitate DIO1-mediated degradation. Conversely, hepatic injury, inflammation, fasting, and regeneration may induce DIO3—normally low in adult liver—favoring hormone inactivation and potentially compounding low-T3 states.

Clinical implications

• During liver illness, interpret thyroid testing cautiously: altered binding proteins, nutrition, infection, medications, and critical illness can affect results. TSH plus free T4 is preferred; isolated low T3 does not itself justify thyroid-hormone therapy, and reverse-T3 testing is not routinely useful.

Bottom line

• The claim is strongly supported: the liver is a major regulator of thyroid-hormone activation, inactivation, conjugation, and disposition. Advanced hepatobiliary disease can materially burden activation; impaired biliary clearance is physiologically well founded, though its human clinical magnitude is less directly quantified.